Cnidoscolus aconitifolius
Cnidoscolus aconitifolius · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Cnidoscolus aconitifolius is a versatile plant species known for its significant medicinal potential across its leaves, stems, and roots. Research indicates that its alcoholic and aqueous extracts possess potent analgesic and antioxidant activities. The plant contains a rich profile of bioactive chemicals, including gallic acid, saponins, terpenes, and cardiac glycosides. These compounds have shown promise in addressing various biological conditions, such as inhibiting lipase and combating cancer, including breast cancer. Consequently, various preparations like ethanolic leaf extracts and methanol extracts of the root bark are being studied for their therapeutic efficacy.
- Synonyms
- Jatropha Aconitifolia
- Common names
- Not available
- Family
- Euphorbiaceae
- Distribution
- Asia-Tropical
- Plant Parts
- Leaf · Root
Classification
Common Names
Cnidoscolus aconitifolius is a versatile plant known by a wide variety of regional names. It is most frequently recognized by the common names Chaya and Chaykol. In different areas, people may also refer to it as Boomspinazie or Chicasquil. Because of its stinging properties, it is sometimes locally called Mala mujer. These diverse names reflect the plant's deep cultural presence across many different landscapes.
Sources: Catalogue of Life (COL)
Synonyms
Cnidoscolus aconitifolius is a plant frequently recognized by botanical researchers under several different names. In many scientific texts, you will encounter it referred to by its synonym, Jatropha aconitifolia. This nomenclatural overlap often occurs as taxonomic classifications evolve over time to better reflect evolutionary lineages. Understanding these synonymous relationships is essential for anyone studying the plant's medicinal or nutritional properties. Consequently, recognizing both terms ensures accuracy when navigating botanical databases and academic literature.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Cnidoscolus aconitifolius belongs to the diverse kingdom Plantae, representing a fascinating branch of the natural world. Within this vast kingdom, the species is classified under the class Equisetopsida. It further refines its biological identity as a member of the order Malpighiales. This botanical lineage continues through its placement in the family Euphorbiaceae. Ultimately, the plant is defined by its specific taxonomic position within the genus Cnidoscolus.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malpighiales |
| Family | Euphorbiaceae |
| Genus | Cnidoscolus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Cnidoscolus aconitifolius exhibits a diverse geographical range that spans across multiple continents and distinct ecological zones. In Asia, this species is found within the tropical regions of Malesia and the Philippines. Moving toward North America, its presence is heavily concentrated throughout various regions of Mexico. Specifically, it thrives in the central, gulf, and northeastern territories of the country. The plant also maintains a significant footprint across the southeastern parts of Mexico, highlighting its wide adaptability.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Cnidoscolus aconitifolius is a self-supporting plant that primarily exhibits a shrub-like growth form. This resilient species can reach a significant stature in the right environment. Depending on its conditions, it typically attains a maximum height of approximately 5 meters. In some instances, the plant may grow even larger, reaching a peak height of up to 5.5 meters.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Cnidoscolus aconitifolius stands out as a significant medicinal plant due to its diverse pharmacological profile. Research indicates that the plant possesses notable analgesic activity, which has been demonstrated through various tests in animal models. Furthermore, studies highlight its beneficial antioxidant properties, suggesting a role in combating oxidative stress. These therapeutic effects are likely linked to the presence of bioactive compounds such as flavonoids and phenolic compounds. Consequently, the species represents a promising source for developing new biotechnological applications in the treatment of numerous diseases.
Compounds
Cnidoscolus aconitifolius is a medicinal plant recognized for its diverse phytochemical profile and potential therapeutic applications. Scientific screenings of its extracts have confirmed the presence of bioactive compounds, including saponins, terpenes, and cardiac glycosides. Beyond these constituents, the plant also contains phenolic compounds such as gallic acid, which contributes to its overall chemical complexity. Research into these extracts has demonstrated remarkable cell growth inhibition against specific breast and lung cancer cell lines. These findings provide a strong scientific basis for the traditional ethnomedicinal uses of the plant in treating various ailments.
Conditions
Cnidoscolus aconitifolius demonstrates significant pharmacological potential through its ability to treat acetic acid-induced abdominal writhing and acetic acid-induced irritation of paws in animal models. The plant also exhibits potent anti-inflammatory properties, as evidenced by its capacity to markedly inhibit carrageenan-induced edema. Furthermore, its bioactive compounds contribute to antioxidant effects that support various beneficial pharmacological actions. Finally, the species shows measurable acute toxicity against Artemia salina, which is closely linked to the concentrations of its secondary metabolites.
Preparations
Cnidoscolus aconitifolius is prepared as alcoholic and aqueous extracts to study the concentration of secondary metabolites and their cytotoxic effects against Artemia salina. Researchers have also utilized an ethanolic leaf extract of the plant to evaluate its significant anti-inflammatory and analgesic properties in animal models. Furthermore, methanol extracts of the leaf have demonstrated remarkable cell growth inhibition against breast and lung cancer cell lines in vitro. Comparative studies have also examined methanol extracts of the stem and methanol extracts of the root barks, though these specific preparations showed no activity at maximum concentrations in certain cancer assays. These various preparation methods highlight the plant's diverse pharmacological potential across different botanical components.
Parts used
Cnidoscolus aconitifolius is a medicinal plant recognized in ethnomedicine for its significant therapeutic potential. Scientific evaluations have utilized various parts of the plant, specifically the leaf, stem, and root, to investigate its pharmacological properties. While ethanolic leaf extracts have demonstrated notable analgesic and anti-inflammatory activities, methanol extracts of the leaf also show remarkable cell growth inhibition against breast and lung cancer lines. In contrast, studies have found that the stem and root extracts exhibited no cytotoxic activity against these specific cancer cell lines at maximum concentrations. These findings highlight the importance of studying different plant components to fully understand the medicinal value of the species.